Press Releases GeneDx Holdings Corp.

Equities

WGS

US81663L2007

Real-time Estimate Cboe BZX Other stock markets 11:37:48 29/04/2024 pm IST			5-day change	1st Jan Change
11.34 ^USD	+2.39%		+9.82%	+314.91%

23/04	Genedx Announces Partnership with Komodo Health to Expand Access to World?S Largest Rare Disease Dataset	CI
15/04	Goldman Sachs Adjusts GeneDx Holdings Price Target to $11 From $6, Maintains Neutral Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset	23/04	AQ
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024	05/04	AQ
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics	14/03	AQ
GeneDx to Participate in 44th Annual Cowen Health Care Conference	27/02	AQ
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024	21/02	AQ
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024	02/02	AQ
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	25/01	AQ
GeneDx Announces Preliminary 2023 Financial Results	08/01	AQ
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy	01/12	AQ
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference	29/11	AQ
Thinking about buying stock in Turnstone Biologics, Iterum Therapeutics, New Gold, GeneDx Holdings, or Tempest Therapeutics?	27/11	PR
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	21/11	AQ
Anagenex Strengthens Board of Directors with Appointments of Robert Forrester and Isaac Ro	17/11	AQ
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights	31/23/31	AQ
GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023	10/23/10	AQ
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23/23/23	AQ
GeneDx : WGS Investor Deck -- September 2023	11/23/11	PU
GeneDx Announces Evolution of Executive Leadership Team	11/23/11	AQ
GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced	06/23/06	AQ
GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine	21/23/21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases GeneDx Holdings Corp.

Equities

WGS

US81663L2007

Press Releases

Filters